Study objective-The aim was to describe changes in the use of hormone replacement therapy (HRT) in Finland during the period 1976-1989. Design-The study involved four separate cross sectional population surveys in the years 1976, 1978-1980, 1987, and 1989 
Hormone replacement therapy (HRT) during the menopause and in the postmenopausal period has been available for more than 40 years. ' At first only oestrogens were used in many countries. Later, when the relation between oestrogen therapy and endometrial cancer was discovered oestrogen-progestin combinations became more common. Researchers have been interested in HRT because of its popularity, its uncertain indications, and the lack of information about side effects from long term use.2 8 The identification of osteoporosis as a major public health problem has been a further stimulus for research.
Despite the popularity of HRT there is little information about HRT users. All previous data on the changes in the use of HRT are based on numbers of prescriptions or sales. In The same methodology as above was used in the 1987 study. The sample size was 13 138 adults and 3131 children, and the participation rate was 850. 10 
SURVEY 3
The Mini-Finland Health Survey in [1978] [1979] [1980] in 40 areas contained an interview, which was methodologically identical with those in the previous two health surveys. The study population consisted of 7612 people, who were at least 30 years old, and the participation rate was 96°0o. SURVEY 4 In 1989 a random sample (n = 2000) of all Finnish women 45-64 years of age was drawn from the Finnish Population Register, and a questionnaire on the menopause and the use of health services and drugs was mailed to them. The answers were anonymous, and those who responded were identified by a name tag which they returned in a separate envelope. The response rate after two reminders was 860O.
The question concerning use of medicines in the studies of 1976, [1978] [1979] [1980] , and 1987 was the following: "What prescription drugs do you use at the moment?" The names of the drugs were copied from the prescription forms or containers for all drugs they were currently using. In the 1989 study, the use of HRT was determined by the question: "Have you used hormones (oestrogens or oestrogen-progestin combinations) during the last month (30 days)? State the name of the drug."
The medicines classified in the Finnish drug compendium, Pharmaca Fennica, for menopausal and postmenopausal hormonal treatment, and containing either oestrogens alone, oestrogens combined to progestins, or oestrogens combined to other drugs, were included. Progestin taken alone was not included. Pharmaca Fennica classifies drugs in a way similar to the ACT classification used by the Nordic Council on Medicines.
In each survey the level of general education included three alternatives: primary school (7-8 years), junior secondary school (9-10 years), and senior secondary school (12-13 years HRT (fig 2) . (The differences between the educational groups were statistically significant, with p at least <0-01.) The educational level of the general population had risen between 1976 and 1989, so that younger age groups were better educated in 1989 than in 1976. For this reason we combined age with education in studying use of HRT. A relationship between education and HRT use was systematic only among women of 55 years or over.
Discussion
Both population surveys and sales statistics produced similar information about a general increase in HRT usage in Finland. The varying data collection method in the 1989 survey as compared to the previous surveys may have influenced the exact estimate of the level of use, but is unlikely to bias the trend. This development in Finland has differed from that in the United States, where use of HRT declined in the mid 1970s and increased again in the 1980s.3-4 17 18 Comparing sales figures, HRT has been used less in Finland than in Denmark and Sweden but more than in Norway.19 20 Studies from other countries have also shown the highest level ofuse to be among 50-54 year old women.8 16 21 At 50-54 years, menopausal symptoms are most prominent. Because in our study period, use also became more common for those aged 55 years and over, the indications for HRT are probably becoming more orientated to the prevention of osteoporosis and other health problems of old age.
The fact that better educated women make more use of HRT has also been found in other studies,8 22 though conflicting results have been published.5 An important finding of the Finnish studies is that the first people to adopt HRT were highly educated women, its use then spreading to other educational groups. The same rule seems to be applicable to the place of residence, with use spreading from the capital metropolitan area to the rural areas. This is similar to certain other health related movements-for example the now widespread use of vitamin supplements in Finland followed the same pattern. An additional fact in this controversial field is that the long term benefits and dangers of HRT are not known. For example there are contradictory results on the association between HRT and breast cancer22 27 28 and cardiovascular diseases.272932 Therefore a cautious attitude towards a widespread use of HRT should probably be adopted.
